The Company's issued share capital consists of 105,326,638 ordinary shares with a nominal value of 5 pence each ("Ordinary Shares"), each share having equal voting rights. The Company does not hold any Ordinary shares in treasury and therefore the number of Ordinary Shares with voting rights is 105,326,638.
The Company's Ordinary Shares are listed on AIM, a market of the London Stock Exchange. The Company's American Depositary Receipts (ADSs) are listed on the Nasdaq Global Market. One ADS represents 8 Ordinary Shares.
In accordance with AIM Rule 26, in so far as the Company is aware, the percentage of the Company's issued share capital that is not in public hands is 40%. The percentage of the Company's issued share capital held by the Directors and management is 0.7%.
Shareholder | % Shareholding |
---|---|
Novo | 11.8 |
Vivo Funds | 11.3 |
OrbiMed | 9.5 |
New Enterprise Associates | 9.3 |
Abingworth | 6.9 |
Ven Bio | 6.7 |
Andera Partners | 5.5 |
Polar Capital | 5.0 |
Tekla | 4.9 |
Aisling | 3.4 |
Arthurian | 3.2 |
Verona Pharma's country of incorporation and main country of operation is the United Kingdom. The Company's registered number is 5375156 and its registered office is at One Central Square, Cardiff CF10 1FS. The Company's principal office is in central London.
The Company's issued share capital consists of 105,326,638 Ordinary Shares with a nominal value of 5 pence each ("Ordinary Shares"), each share having equal voting rights.
The Company does not hold any Ordinary shares in treasury and therefore the number of Ordinary Shares with voting rights is 105,326,638.
In accordance with AIM Rule 26, in so far as the Company is aware, the percentage of the Company's issued share capital that is not in public hands is 40%. The percentage of the Company's issued share capital held by the Directors and management is 0.7%. There are no restrictions on the transfer of the Company's securities.
The Company's American Depository Shares (ADSs) are listed on The Nasdaq Global Market under the symbol “VRNA”. Verona Pharma's ordinary shares are listed on AIM, a market of the London Stock Exchange, under the symbol “VRP”. One ADS represents 8 Ordinary Shares.
The Company's annual and half-yearly accounts published since Admission can be found here.
The Company will be subject to the provisions of the City Code on Takeovers and Mergers published by the Takeover Panel, including the rules regarding mandatory takeover bids.
The Company's Articles of Association can be found here. The Company’s 2006 Admission document can be found here. The last published Shareholders' Circular for the Company can be found here. The Company's 2019 AGM Notice can be found here.